Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA)

Treatment for Congenital heart anomalies

Effectiveness
95%
Safety Score
45%
Clinical Trials
1
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (hemodynamic correction), critical early recovery, long-term monitoring
Treatment Duration
Single procedure (neonatal), lifetime specialized cardiac care
Evidence Quality
HIGH
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$1,500
Side Effect Mgmt:$400
Total Annual:$2,100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$40,000/QALY
QALYs Gained
25
Outcome-Based Costs
Cost per Responder
$2,210.53
Cost per Remission
$2,333.33
Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA) Outcomes

for Congenital heart anomalies

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Coronary artery stenosis
+5%
Supravalvular pulmonary stenosis
+10%
Neoaortic root dilation/regurgitation
+15%
Arrhythmias
+5%
Mortality
+3%

Sources:

nih.gov
researchgate.net
ahajournals.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov